Transgender health care

Transgender health care includes the prevention, diagnosis and treatment of physical and mental health conditions, as well as sex reassignment therapies, for transgender individuals.[1] Questions implicated in transgender health care include gender variance, sex reassignment therapy, health risks (in relation to violence and mental health), and access to healthcare for trans people in different countries around the world.

Gender variance and medicine

Gender variance is defined in medical literature as "gender identity, expression, or behavior that falls outside of culturally defined norms associated with a specific gender".[2] For centuries, gender variance was seen by medicine as a pathology.[3][4] The World Health Organization identified gender dysphoria as a mental disorder in the International Classification of Diseases (ICD) until 2018.[5] Gender dysphoria was also listed in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) of the American Psychiatric Association, where it was previously called "transsexualism" and "gender identity disorder".[6][7]

In 2018, the ICD-11 included the term "gender incongruence" as "marked and persistent incongruence between an individual’s experienced gender and the assigned sex", where gender variant behaviour and preferences do not necessarily imply a medical diagnosis.[8] However, the difference between "gender dysphoria" and "gender incongruence" is not always clear in the medical literature.[9]

Some studies posit that treating gender variance as a medical condition has negative effects on the health of transgender people and claim that assumptions of coexisting psychiatric symptoms should be avoided.[3][10][11] Other studies argue that gender incongruence diagnosis may be important and even positive for transgender people at the individual and social level.[12]

As there are various ways of classifying or characterizing those who are either diagnosed or self-affirm as transgender individuals, the literature cannot clearly estimate how prevalent these experiences are within the total population. The results of a recent systematic review highlight the need to standardize the scope and methodology related to data collection of those presenting as transgender.[13]

Sex reassignment therapy

Various options are available for transgender people to pursue physical transition. There have been options for transitioning for transgender individuals since 1917.[1] Sex reassignment therapy helps people to change their physical appearance and/or sex characteristics to accord with their gender identity; it includes hormone replacement therapy and sex reassignment surgery. While many transgender people do elect to transition physically, every transgender person has different needs and, as such, there is no required transition plan.[14] Preventive health care is a crucial part of transitioning and a primary care physician is recommended for transgender people who are transitioning.[14]

Hormone replacement therapy

A transgender woman before and after two years of hormone replacement therapy.

Hormone replacement therapy is primarily concerned with alleviating gender dysphoria in transgender people.[14] Trans women are usually treated with estrogen and complementary anti-androgenic therapy. This therapy induces breast formation, reduces male hair pattern growth, and changes fat distribution, also leading to a decreased testicular size and erectile function.[15] Trans men are normally treated with exogenous testosterone, which is expected to cease menses, to increase facial and body hair, to cause changes in skin and in fat distribution, and to increase muscle mass and libido.[15] After at least three months, other effects are expected, such as the deepening of the voice and changes in sexual organs (such as atrophy of vaginal tissues, and increased clitoral size).[15] Regular monitoring by an endocrinologist is a strong recommendation to ensure the safety of individuals as they transition.[16]

Access to hormone replacement therapy has been shown to improve quality of life for people in the female-to-male community when compared to female-to-male people who do not have access to hormone replacement therapy.[17] Despite the improvement in quality of life, there are still dangers with hormone replacement therapy, in particular with self-medication. An examination of the use of self-medication found that people who self-medicated were more likely to experience adverse health effects from preexisting conditions such as high blood pressure as well as slower development of desired secondary sex characteristics.[18]

Hormone therapy for transgender individuals has been shown in medical literature to be safe, when supervised by a qualified medical professional.[19]

Transgender people seeking surgery may be informed they will need to take hormones for the rest of their life if they want to maintain the feminizing effects of oestrogen or the masculinizing effects of testosterone. Their dose of hormones will usually be reduced, but it should still be enough to produce the effects that they need and to keep them well, and to protect them against osteoporosis (thinning of the bones) as they get older. If they are still on hormone blockers, they will stop taking them altogether.[20]

Monitoring of risk factors associated with hormone replacement therapy, such as prolactin levels in transgender women and polycythemia levels in transgender men, are crucial for the preventive health care of transgender people taking these treatments.[14]

Sex reassignment surgery

The goal of sex reassignment surgery, also known as gender reassignment surgery, is to align the secondary sexual characteristics of transgender people with their gender identity. As hormone replacement therapy, sex reassignment surgery was also employed as a response to diagnosis gender dysphoria [14][21]

The World Professional Association for Transgender Health (WPATH) Standards of Care recommend additional requirements for sex reassignment surgery when compared to hormone replacement therapy. Whereas hormone replacement therapy can be obtained through something as simple as an informed consent form, sex reassignment surgery can require a supporting letter from a licensed therapist (two letters for genital surgery such as vaginoplasty or phalloplasty), hormonal treatment, and (for genital surgery) completion of a 12-month period in which the person lives full-time as their gender. WPATH standards, while commonly used in gender clinics, are non-binding; many trans patients undergoing surgery do not meet all of the eligibility criteria.

Issues affecting transgender patients

Violence

The heightened levels of violence and abuse that transgender people experience result in unique adverse effects on bodily and mental health.[22] Specifically, in resource-constrained settings where non-discriminatory policies may be limited or not enforced, transgender people may encounter high rates of stigma and violence which are associated with poor health outcomes.[23][24] Studies in countries of the Global North show higher levels of discrimination and harassment in school, workplace, healthcare services and the family when compared with cisgender populations, situating transphobia as a key health risk factor for the physical and mental health of transgender people.[25]

There is limited data regarding the impact of social determinants of health on transgender and gender non-conforming individuals health outcomes.[26] However, despite the limited data available, transgender and gender non-conforming individuals have been found to be at higher risk of experiencing poor health outcomes and restricted access to health care due to increased risk for violence, isolation, and other types of discrimination both inside and outside the health care setting.[27]

Despite its importance, access to preventive care is also limited by several factors, including discrimination and erasure. A study on young transgender women's access to HIV treatment found that one of the main contributors to not accessing care was the use of incorrect name and pronouns.[28] A meta analysis of the National Transgender Discrimination Survey examined respondents who used the "gender not listed here" option on the survey and their experiences with accessing health care. Over a third of the people who chose that option said that they had avoided accessing general care due to bias and fears of social repercussions.[29]

Mental health

Transgender individuals may experience distress and sadness as a result of their gender identity being inconsistent with their biological sex. This distress is referred to as gender dysphoria.[30] Gender dysphoria is typically most upsetting for the individual prior to transitioning, and once the individual begins to transition into their desired gender, whether the transition be socially, medically, or both, the distress frequently lessens.[31][32][33]

Those who are transgender are significantly more likely to be diagnosed with anxiety disorders or depression than the general population.[31][32][33][34] A number of studies suggest that the inflated rates of depression and anxiety in transgender individuals may partially be because of systematic discrimination or a lack of support.[35][36] Evidence suggests that these increased rates begin to normalize when transgender individuals are accepted as their identified gender and when they live within a supportive household.[35][36][37]

Many studies report extremely high rates of suicide within the transgender community.[31][34] A United States study of 6,450 transgender individuals found that 41% of them had attempted suicide, as differing from the national average of 4.6%. The very same survey found that these rates were the most high for certain demographics, with transgender youth between the ages of 18 and 24 having the highest percent.[38] Individuals in the survey who were multiracial, had lower levels of education, and those with a lower annual income were all more likely to have attempted.[38] Specifically, transgender males as a group are the most likely to attempt suicide, more so than transgender females.[38][39] Later surveys suggest that the rate of suicidal attempts for non-binary individuals is in between the two.[39] Transgender adults who have "de-transitioned", meaning having gone back to living as their sex assigned at birth, are significantly more likely to attempt suicide than transgender adults who have never "de-transitioned".[40]

Several studies have shown the relation between minority stress and the heightened rate of depression and other mental illness among both transgender men and women.[41] The expectation to experience rejection can become an important stressor for transgender and gender non-conforming individuals.[42] Mental health problems among trans people are related to higher rates of self-harm, drug usage, and suicidal ideations and attempts.[25]

Health experiences

Trans people are a vulnerable population of patients with negative experiences in health care contributing to stigmatization of their gender identity. As noted by a systematic review conducted by researchers at James Cook University, evidence reports that 75.3% of respondents have negative experiences during physician visits when seeking gender identity-based care.[43]

Clinic environment

Guidelines from the UCSF Transgender Care Center state the importance of visibility in chosen gender identity for transgender or non-binary patients. Safe environments include a two-step process in collecting gender identity data by differentiating between personal identity and assignments at birth for medical histories. Common techniques recommended are asking patients their preferred name, pronouns, and other names they may go by in legal documents. In addition, visibility of non-cisgender identities is defined by the work environment of the clinic. Front-desk staff and medical assistants will interact with patients, which these guidelines recommend appropriate training. The existence of at least one gender-neutral bathroom shows consideration of patients with non-binary gender identities.[44]

Global access to transgender health care

Africa

South Africa

Access to transition care, mental care, and other issues affecting transgender people is very limited; there is only one comprehensive transgender health care clinic available in South Africa.[45] Additionally, the typical lack of access to transition options that comes as a result of gatekeeping is compounded by the relatively limited knowledge of transgender topics among psychiatrists and psychologists in South Africa.[45]

Asia

Thailand

Transgender women, known as kathoeys, have access to hormones through non-prescription sources.[46] This kind of access is a result of the low availability and expense of transgender health care clinics.[46] However, transgender men have difficulty gaining access to hormones such as testosterone in Thailand because it is not as readily available as hormones for kathoeys.[47] As a result, just a third of all trans men surveyed are taking hormones to transition whereas almost three quarters of kathoeys surveyed are taking hormones.[47]

Mainland China

In Mainland China access to resources and HRT prescriptions are rare, and as a result most people resort to hormones through non-prescription resources. The resources of accessing hormone including Peking University Third Hospital, Dr.Liu(刘烨)and Dr. Pan(潘柏林), Zhongshan Hospital, Dr. Li (李小英), And Shanghai Ninth People's Hospital, Dr. Cheng (程辰). In Changhai Hospital of Shanghai (Hongkou division), Dr. Zhao (赵烨德) can do both HRT prescriptions and SRS.[48]

Europe

Spain

Public health care services are available for transgender individuals in Spain, although there has been debate over whether certain procedures should be covered under the public system.[49] The region of Andalusia was the first to approve sex reassignment procedures, including sex reassignment surgery and mastectomies, in 1999, and several other regions have followed their lead in the following years. Multiple interdisciplinary clinics exist in Spain to cater specifically to diagnosing and treating transgender patients, including the Andalusian Gender Team.[49][50] As of 2013, over 4000 transgender patients had been treated in Spain, including Spaniards and international patients.[49][51]

Beginning in 2007, Spain has begun allowing transgender individuals who are eighteen years or older to change their name and gender identity on public records and documents if they have been receiving hormone replacement therapy for at least two years.[49]

Sweden

In 1972, Sweden introduced a law that made it possible to change a person's legal gender, but in order to do that, transgender individuals were required to be sterilized and were not allowed to save any sperm or eggs. Apart from this, there were no other mandatory surgeries required for legal gender change.[52] In 1999, people who had been forcibly sterilized in Sweden were entitled to compensation. However, the sterilization requirement remained for people who changed their legal gender. In January 2013, forced sterilization was banned in Sweden.[53]

Depending on the persons health and wishes there are a number of different treatments and surgeries available. Today, no form of treatment is mandatory. An individual with a transsexual or gender dysphoria diagnosis can, together with the assessment team and other doctors, decide what suits them. Although, in order to access medical and legal transitional treatment (e.g. hormone replacement therapy, and top surgery to enhance or remove breast tissue), the person will need to be diagnosed with transexualism or gender dysphoria, which requires at least one year of therapy.[54] To medically transition can cost a lot of money, but in Sweden, the whole treatment is covered by the high-cost protection for medications and doctor's visits and there is no surgery fee. The fee the individual pays for a doctor's appointment or other care represents only a small fraction of the actual costs.[55] If a person would like to change their legal gender marker and personal identity number they will have to seek permission from the National Board of Health and Welfare.[54] For non-binary persons younger than 18 years, the healthcare is very limited. These individuals do not have access to a legal gender marker change or bottom surgery.[56]

In Sweden, anyone is allowed to change their name at any time, including for gender transition.[57]

Up until January 27, 2017, being transsexual was classed as a disease. Two months earlier, in November 21, 2016, around 50 trans activists broke into and occupied the Swedish National Board of Health and Welfare (Swedish: Socialstyrelsen) premises in Rålambsvägen in Stockholm. The activists demanded that their voices be heard regarding the way the country, healthcare, and the National Board of Health and Welfare mistreat transgender and intersex individuals.[58]

Netherlands

Gender care in the Netherlands is insured under the national health care of third part insurer’s, including lazer hair removal, SRS, facial feminization surgery and hormones. Hormones can be prescribed by licensed endocrinologist in a academic hospital from the age 16 and older. Blockers can be prescribed from age 12 when puberty usually starts.

United Kingdom

A sign at a rally calling for equal access to health care for transgender people

A 2013 survey of gender identity clinic services provided by the UK National Health Service (NHS) found that 94% of transgender people using the gender identity clinics were satisfied with their care and would recommend the clinics to a friend or family member.[59] This study focused on transgender people using the NHS clinics and so was prone to survivorship bias, as those unhappy with the NHS service are less likely to use it. Despite this positive response, however, other National Health Service programs are lacking; almost a third of respondents reported inadequate psychiatric care in their local area.[59] The options available from the National Health Service also vary with location; slightly differing protocols are used in England, Scotland, Wales and Northern Ireland. Protocols and available options differ widely outside of the UK.[59]

In 2018 Stonewall described UK transgender healthcare as having "significant barriers to accessing treatment, including waiting times that stretch into years, far exceeding the maximums set by law for NHS patients".[60]

North America

Canada

A study of transgender Ontario residents aged 16 and over, published in 2016, found that half of them were reluctant to discuss transgender issues with their family doctor.[61] A 2013-2014 nationwide study of young transgender and genderqueer Canadians found that a third of younger (ages 14–18) and half of the older (ages 19–25) respondents missed needed physical health care. Only 15 percent of respondents with a family doctor felt very comfortable discussing transgender issues with them.[62]

All Canadian provinces fund some sex reassignment surgeries, with New Brunswick being the last of the provinces to start insuring these procedures in 2016.[63] Waiting times for surgeries can be lengthy, as few surgeons in the country provide them; a clinic in Montreal is the only one providing a full range of procedures.[64][65][66] Insurance coverage is not generally provided for the transition-related procedures of facial feminization surgery, tracheal shave, or laser hair removal.[67]

Blood donation

Canada's blood collection organization Canadian Blood Services has eligibility criteria for transgender people, which came into effect on August 15, 2016. This criteria states that transgender donors who have not had lower gender affirming surgery will be asked questions based on their sex assigned at birth. They will be eligible to donate or be deferred based on these criteria. For example, trans women will be asked if they have had sex with a man in the last 3 months. If the response is yes, they will be deferred for 3 months after their last sexual contact with a man. Donors who have had lower gender affirming surgery will be deferred from donating blood for 3 months after their surgery. After those months, these donors will be screened in their affirmed gender.[68][69][70]

Mexico

A July 2016 study in The Lancet Psychiatry reported that nearly half of transgender people surveyed undertook body-altering procedures without medical supervision.[71] Transition-related care is not covered under Mexico's national health plan.[72] Only one public health institution in Mexico provides free hormones for transgender people.[71] Health care for transgender Mexicans focuses on HIV and prevention of other sexually transmitted diseases.[71]

The Lancet study also found that many transgender Mexicans have physical health problems due to living on the margins of society. The authors of the study recommended that the World Health Organization declassify transgender identity as a mental disorder, to reduce stigma against this population.[73]

United States

Transgender people face various kinds of discrimination, especially in health care situations. An assessment of transgender needs in Philadelphia found that 26% of respondents had been denied health care because they were transgender and 52% of respondents had difficulty accessing health services.[74] Aside from transition related care, transgender and gender non-conforming individuals need preventive care such as vaccines, gynecological care, prostate exams, and other annual preventive health measures.[1] Various factors play a role in creating the limited access to care, such as insurance coverage issues related to their legal gender identity status.[1]

The Affordable Care Act (commonly known as Obamacare) marketplace has improved access to insurance for the LGBT community through anti-discriminatory measures, such as not allowing insurance companies to reject consumers for being transgender.[26] However, insurance sold outside of the ACA marketplace does not have to follow these requirements. This means that preventive care, such as gynecological exams for transgender men, may not be covered.[75]

South America

Colombia

Transgender women sex workers have cited financial difficulties as barriers to accessing physical transition options.[76] As a result, they have entered sex work to relieve financial burdens, both those related to transition and those not related to transition.[76] However, despite working in the sex trade, the transgender women are at low risk for HIV transmission as the Colombian government requires education about sexual health and human rights for sex workers to work in so-called tolerance zones, areas where sex work is legal.[76]

Health care for transgender youth

Transition options for transgender adolescents and youth are significantly limited compared to those for transgender adults. Prepubescent transgender youth can go through various social changes, such as presenting as their gender and asking to be called by a different name or different pronouns.[77] Medical options for transition become available once the child begins to enter puberty. Under close supervision by a team of doctors, puberty blockers may be used to limit the effects of puberty.[77]

Discrimination has a significant effect on the mental health of young transgender people. The lack of family acceptance, rejection in schools and abuse from peers can be powerful stressors, leading to poor mental health and substance abuse.[78] A study done on transgender youth in San Francisco found that higher rates of both transgender-based and racial bias are associated with increased rates of depression, post-traumatic stress disorder, and suicidal ideation.[79]

The use of puberty blockers as a form of treatment for transgender youth is in question. While the World Professional Association for Transgender Health recommends their use, the likelihood of issues of gender dysphoria resolving before adolescence and before the use of puberty blockers are quite high.[14][80] Concerns regarding the impact of puberty blockers on physical health, such as bone density, have also been raised.[80] Long-term use of puberty blockers has also gone relatively unstudied, bringing up questions about harmful long-term side effects.[80] While there is concern about the physical effects of puberty blockers, the mental effects are positive with treatment associated with significant improvements in multiple psychological measures, including global functioning, depression, and overall behavioral and/or emotional problems.[81]

Health care for transgender older adults

Transgender older adults can encounter challenges in the access and quality of care received in health care systems and nursing homes, where providers may be ill-prepared to provide culturally sensitive care to trans people.[82] Trans individuals face the risk of aging with more limited support and in more stigmatizing environments than heteronormative individuals.[83] Despite the rather negative picture portrayed by medical literature in relation to the depression and isolation that many transgender people encounter at earlier stages of life, some studies found testimonies of older LGBT adults relating feelings of inclusion, comfort and community support.[84]

See also

References

  1. 1 2 3 4 Gorton N, Grubb HM (2014). General, Sexual, and Reproductive health. In L. Erickson-Schroth. Trans Bodies, Trans Selves: A Resource for the transgender community (pp. 215-240). New York: Oxford University Press.
  2. ↑ Simons, Lisa K.; Leibowitz, Scott F.; Hidalgo, Marco A. (2014-06-01). "Understanding Gender Variance in Children and Adolescents". Pediatric Annals. 43 (6): e126–e131. doi:10.3928/00904481-20140522-07. ISSN 0090-4481. PMID 24972420.
  3. 1 2 Byne, William; Karasic, Dan H.; Coleman, Eli; Eyler, A. Evan; Kidd, Jeremy D.; Meyer-Bahlburg, Heino F.L.; Pleak, Richard R.; Pula, Jack (May 2018). "Gender Dysphoria in Adults: An Overview and Primer for Psychiatrists". Transgender Health. 3 (1): 57–A3. doi:10.1089/trgh.2017.0053. ISSN 2380-193X. PMC 5944396. PMID 29756044.
  4. ↑ von Krafft-Ebing, Richard (1894). Psychopathia Sexualis. ISBN 9782357792173.
  5. ↑ Reed, Geoffrey M.; Drescher, Jack; Krueger, Richard B.; Atalla, Elham; Cochran, Susan D.; First, Michael B.; Cohen-Kettenis, Peggy T.; Arango-de Montis, Iván; Parish, Sharon J. (October 2016). "Disorders related to sexuality and gender identity in the ICD-11: revising the ICD-10 classification based on current scientific evidence, best clinical practices, and human rights considerations". World Psychiatry. 15 (3): 205–221. doi:10.1002/wps.20354. PMC 5032510. PMID 27717275.
  6. ↑ Reed, Geoffrey M.; Drescher, Jack; Krueger, Richard B.; Atalla, Elham; Cochran, Susan D.; First, Michael B.; Cohen-Kettenis, Peggy T.; Arango-de Montis, Iván; Parish, Sharon J. (October 2016). "Disorders related to sexuality and gender identity in the ICD-11: revising the ICD-10 classification based on current scientific evidence, best clinical practices, and human rights considerations". World Psychiatry. 15 (3): 205–221. doi:10.1002/wps.20354. PMC 5032510. PMID 27717275.
  7. ↑ Cohen-Kettenis, Peggy T.; Pfäfflin, Friedemann (2009-10-17). "The DSM Diagnostic Criteria for Gender Identity Disorder in Adolescents and Adults". Archives of Sexual Behavior. 39 (2): 499–513. doi:10.1007/s10508-009-9562-y. hdl:1871/34512. ISSN 0004-0002. PMID 19838784. S2CID 16336939.
  8. ↑ "ICD-11". icd.who.int. Retrieved 2019-03-24.
  9. ↑ Defreyne, Justine; Kreukels, Baudewijntje; T'Sjoen, Guy; Staphorsius, Annemieke; Den Heijer, Martin; Heylens, Gunter; Elaut, Els (April 2019). "No correlation between serum testosterone levels and state-level anger intensity in transgender people: Results from the European Network for the Investigation of Gender Incongruence". Hormones and Behavior. 110: 29–39. doi:10.1016/j.yhbeh.2019.02.016. PMID 30822410. S2CID 72332772.
  10. ↑ Castro-Peraza, Maria Elisa; García-Acosta, Jesús Manuel; Delgado, Naira; Perdomo-Hernández, Ana María; Sosa-Alvarez, Maria Inmaculada; Llabrés-Solé, Rosa; Lorenzo-Rocha, Nieves Doria (2019-03-18). "Gender Identity: The Human Right of Depathologization". International Journal of Environmental Research and Public Health. 16 (6): 978. doi:10.3390/ijerph16060978. ISSN 1660-4601. PMC 6466167. PMID 30889934.
  11. ↑ Latham, J.R. (2017). "Making and Treating Trans Problems The Ontological Politics of Clinical Practices". Studies in Gender and Sexuality. 18 (1): 40–61. doi:10.1080/15240657.2016.1238682. S2CID 152123850.
  12. ↑ Vargas-Huicochea, Ingrid; Robles, Rebeca; Real, Tania; Fresán, Ana; Cruz-Islas, Jeremy; Vega-Ramírez, Hamid; Medina-Mora, María Elena (November 2018). "A Qualitative Study of the Acceptability of the Proposed ICD-11 Gender Incongruence of Childhood Diagnosis Among Transgender Adults Who Were Labeled Due to Their Gender Identity Since Childhood". Archives of Sexual Behavior. 47 (8): 2363–2374. doi:10.1007/s10508-018-1241-4. ISSN 0004-0002. PMID 29971651. S2CID 49681691.
  13. ↑ Collin, Lindsay; Reisner, Sari L.; Tangpricha, Vin; Goodman, Michael (2016). "Prevalence of Transgender Depends on the "Case" Definition: A Systematic Review". The Journal of Sexual Medicine. 13 (4): 613–626. doi:10.1016/j.jsxm.2016.02.001. PMC 4823815. PMID 27045261.
  14. 1 2 3 4 5 6 Coleman, E.; Bockting, W.; Botzer, M.; Cohen-Kettenis, P.; DeCuypere, G.; Feldman, J.; Fraser, L.; Green, J.; Knudson, G. (2012-08-01). "Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7". International Journal of Transgenderism. 13 (4): 165–232. doi:10.1080/15532739.2011.700873. ISSN 1553-2739. S2CID 39664779.
  15. 1 2 3 Unger, Cécile A. (December 2016). "Hormone therapy for transgender patients". Translational Andrology and Urology. 5 (6): 877–884. doi:10.21037/tau.2016.09.04. PMC 5182227. PMID 28078219.
  16. ↑ Moore, Eva; Wisniewski, Amy; Dobs, Adrian (2003-08-01). "Endocrine Treatment of Transsexual People: A Review of Treatment Regimens, Outcomes, and Adverse Effects". The Journal of Clinical Endocrinology & Metabolism. 88 (8): 3467–3473. doi:10.1210/jc.2002-021967. ISSN 0021-972X. PMID 12915619.
  17. ↑ Newfield, Emily; Hart, Stacey; Dibble, Suzanne; Kohler, Lori (2006-06-07). "Female-to-male transgender quality of life". Quality of Life Research. 15 (9): 1447–1457. CiteSeerX 10.1.1.468.9106. doi:10.1007/s11136-006-0002-3. ISSN 0962-9343. PMID 16758113. S2CID 12727036.
  18. ↑ Israel, Gianna (2001). Transgender Care: Recommended Guidelines, Practical Information, and Personal Accounts. Temple University Press. ISBN 978-1566398527.
  19. ↑ Weinand, Jamie D.; Safer, Joshua D. (Feb 2015). "Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals". Journal of Clinical & Translational Endocrinology. 2 (2): 55–60. doi:10.1016/j.jcte.2015.02.003. PMC 5226129. PMID 28090436.
  20. ↑ "A guide to hormone therapy for trans people" (PDF). August 2014. p. 10. Retrieved March 2, 2021.
  21. ↑ Choices, NHS. "Gender dysphoria - NHS Choices". www.nhs.uk. Retrieved 9 December 2016.
  22. ↑ Rood, Brian A.; Reisner, Sari L.; Surace, Francisco I.; Puckett, Jae A.; Maroney, Meredith R.; Pantalone, David W. (2016). "Expecting Rejection: Understanding the Minority Stress Experiences of Transgender and Gender-Nonconforming Individuals". Transgender Health. 1 (1): 151–164. doi:10.1089/trgh.2016.0012. PMC 5685272. PMID 29159306.
  23. ↑ Budhwani, Henna; Hearld, Kristine R.; Milner, Adrienne N.; Charow, Rebecca; McGlaughlin, Elaine M.; Rodriguez-Lauzurique, Mayra; Rosario, Santo; Paulino-Ramirez, Robert (September 26, 2017). "Transgender Women's Experiences with Stigma, Trauma, and Attempted Suicide in the Dominican Republic". Suicide and Life-Threatening Behavior. 48 (6): 788–796. doi:10.1111/sltb.12400. ISSN 1943-278X. PMID 28950402. S2CID 26033883.
  24. ↑ Lagos, Danya (December 2018). "Looking at Population Health Beyond "Male" and "Female": Implications of Transgender Identity and Gender Nonconformity for Population Health". Demography. 55 (6): 2097–2117. doi:10.1007/s13524-018-0714-3. ISSN 0070-3370. PMID 30255426. S2CID 52822267.
  25. 1 2 Scherer, Bee (2018-12-20). Queering paradigms VII : contested bodies and spaces. Scherer, Burkhard, 1971-, Vries, Patrick de. Oxford, United Kingdom. ISBN 978-1788745291. OCLC 1080428040.
  26. 1 2 Department of Health and Human Services, Office of Disease and Health Promotion. (2016, September). Lesbian, Gay, Bisexual, and Transgender Health. Retrieved from HealthyPeople.gov: https://www.healthypeople.gov/2020/topics-objectives/topic/lesbian-gay-bisexual-and-transgender-health
  27. ↑ Anastas, J.W. (2013). "Policy, practice, and people: Current issues affecting clinical practice". Clinical Social Work Journal. 41 (3): 302–307. doi:10.1007/s10615-013-0454-1. S2CID 143288898.
  28. ↑ Dowshen, Nadia; Lee, Susan S.; Castillo, Marné; Hawkins, Linda; Barg, Frances K. (February 2016). "Barriers and Facilitators to HIV Prevention, Testing, and Treatment among Young Transgender Women". Journal of Adolescent Health. 58 (2): S81–S82. doi:10.1016/j.jadohealth.2015.10.175.
  29. ↑ Jack, Harrison; Jaime, Grant; L., Herman, Jody (2012-04-01). "A Gender Not Listed Here: Genderqueers, Gender Rebels, and OtherWise in the National Transgender Discrimination Survey". LGBTQ Public Policy Journal at the Harvard Kennedy School. 2 (1).
  30. ↑ "What Does Transgender Mean? | Gender Identification Facts". www.plannedparenthood.org. Retrieved 2019-10-23.
  31. 1 2 3 Connolly, Maureen D.; Zervos, Marcus J.; Barone, Charles J.; Johnson, Christine C.; Joseph, Christine L. M. (2016-11-01). "The Mental Health of Transgender Youth: Advances in Understanding". Journal of Adolescent Health. 59 (5): 489–495. doi:10.1016/j.jadohealth.2016.06.012. ISSN 1054-139X. PMID 27544457.
  32. 1 2 Dhejne, Cecilia; Vlerken, Roy Van; Heylens, Gunter; Arcelus, Jon (2016-01-02). "Mental health and gender dysphoria: A review of the literature". International Review of Psychiatry. 28 (1): 44–57. doi:10.3109/09540261.2015.1115753. ISSN 0954-0261. PMID 26835611. S2CID 207493538.
  33. 1 2 Bouman, Walter Pierre; Claes, Laurence; Brewin, Nicky; Crawford, John R.; Millet, Nessa; Fernandez-Aranda, Fernando; Arcelus, Jon (2017-01-02). "Transgender and anxiety: A comparative study between transgender people and the general population" (PDF). International Journal of Transgenderism. 18 (1): 16–26. doi:10.1080/15532739.2016.1258352. ISSN 1553-2739. S2CID 151463685.
  34. 1 2 Zucker, Kenneth J.; Lawrence, Anne A.; Kreukels, Baudewijntje P.C. (2016). "Gender Dysphoria in Adults". Annual Review of Clinical Psychology. 12 (1): 217–247. doi:10.1146/annurev-clinpsy-021815-093034. PMID 26788901.
  35. 1 2 Trujillo, Michael A.; Perrin, Paul B.; Sutter, Megan; Tabaac, Ariella; Benotsch, Eric G. (2017-01-02). "The buffering role of social support on the associations among discrimination, mental health, and suicidality in a transgender sample". International Journal of Transgenderism. 18 (1): 39–52. doi:10.1080/15532739.2016.1247405. ISSN 1553-2739. PMC 5996383. PMID 29904324.
  36. 1 2 McConnell, Elizabeth A.; Birkett, Michelle; Mustanski, Brian (2016-12-01). "Families Matter: Social Support and Mental Health Trajectories Among Lesbian, Gay, Bisexual, and Transgender Youth". Journal of Adolescent Health. 59 (6): 674–680. doi:10.1016/j.jadohealth.2016.07.026. ISSN 1054-139X. PMC 5217458. PMID 27707515.
  37. ↑ Durwood, Lily; McLaughlin, Katie A.; Olson, Kristina R. (February 2017). "Mental Health and Self-Worth in Socially Transitioned Transgender Youth". Journal of the American Academy of Child & Adolescent Psychiatry. 56 (2): 116–123.e2. doi:10.1016/j.jaac.2016.10.016. PMC 5302003. PMID 28117057.
  38. 1 2 3 Haas, Ann; Rodgers, Philip; Herman, Jody (2017-10-08). "Suicide Attempts among Transgender and Gender Non-Conforming Adults" (PDF). The Williams Institute. Archived (PDF) from the original on 2017-10-08. Retrieved 2019-10-23.
  39. 1 2 Toomey, Russell B.; Syvertsen, Amy K.; Shramko, Maura (2018-10-01). "Transgender Adolescent Suicide Behavior". Pediatrics. 142 (4): e20174218. doi:10.1542/peds.2017-4218. ISSN 0031-4005. PMC 6317573. PMID 30206149.
  40. ↑ Herman, Jody L.; Brown, Taylor N.T.; Haas, Ann P. (September 2019). "Suicide Thoughts and Attempts Among Transgender Adults: Findings from the 2015 U.S. Transgender Survey" (PDF). Williams Institute. Retrieved 5 November 2020.
  41. ↑ Bockting, Walter O.; Miner, Michael H.; Swinburne Romine, Rebecca E.; Hamilton, Autumn; Coleman, Eli (2013). "Stigma, mental health, and resilience in an online sample of the US transgender population". American Journal of Public Health. 103 (5): 943–951. doi:10.2105/ajph.2013.301241. PMC 3698807. PMID 23488522.
  42. ↑ Rood, Brian A.; Reisner, Sari L.; Surace, Francisco I.; Puckett, Jae A.; Maroney, Meredith R.; Pantalone, David W. (January 2016). "Expecting Rejection: Understanding the Minority Stress Experiences of Transgender and Gender-Nonconforming Individuals". Transgender Health. 1 (1): 151–164. doi:10.1089/trgh.2016.0012. ISSN 2380-193X. PMC 5685272. PMID 29159306.
  43. ↑ Heng, Audrey; Heal, Clare; Banks, Jennifer; Preston, Robyn (2018-10-02). "Transgender peoples' experiences and perspectives about general healthcare: A systematic review" (PDF). International Journal of Transgenderism. 19 (4): 359–378. doi:10.1080/15532739.2018.1502711. ISSN 1553-2739. S2CID 150322054.
  44. ↑ "Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People | Transgender Care". transcare.ucsf.edu. Retrieved 2019-08-06.
  45. 1 2 Wilson, D.; Marais, A.; de Villiers, A.; Addinall, R.; Campbell, M. M. (2014-06-01). "Transgender issues in South Africa, with particular reference to the Groote Schuur Hospital Transgender Unit". South African Medical Journal. 104 (6): 448–449. doi:10.7196/SAMJ.8392. ISSN 0256-9574. PMID 26301294.
  46. 1 2 Gooren, Louis J; Sungkaew, Tanapong; Giltay, Erik J (2013). "Exploration of functional health, mental well-being and cross-sex hormone use in a sample of Thai male-to-female transgendered persons (kathoeys)". Asian Journal of Andrology. 15 (2): 280–285. doi:10.1038/aja.2012.139. PMC 3739151. PMID 23353716.
  47. 1 2 Gooren, Louis J.; Sungkaew, Tanapong; Giltay, Erik J.; Guadamuz, Thomas E. (2015-01-02). "Cross-sex hormone use, functional health and mental well-being among transgender men and Transgender Women (Kathoeys) in Thailand". Culture, Health & Sexuality. 17 (1): 92–103. doi:10.1080/13691058.2014.950982. ISSN 1369-1058. PMC 4227918. PMID 25270637.
  48. ↑ "目前已知与性别认同相关的医疗资源列表" [List of currently known medical resources related to gender identity] (in Chinese). Retrieved March 2, 2021.
  49. 1 2 3 4 Esteva de Antonio, Isabel; Gómez-Gil, Esther (December 2013). "Coordination of healthcare for transsexual persons". Current Opinion in Endocrinology, Diabetes and Obesity. 20 (6): 585–591. doi:10.1097/01.med.0000436182.42966.31. PMID 24468763. S2CID 36430944.
  50. ↑ Giraldo, F.; Antonio, I. Esteva de; Miguel, T. Bergero de; Maté, A.; González, C.; Baena, V.; Martín-Morales, A.; Tinoco, I.; Cano, G. (2001-10-01). "Andalusia (Málaga) Gender Team. Surgical experience treating transsexuals in the first and only unit in the Spanish Public Health System". ResearchGate. 27 (4). ISSN 0376-7892.
  51. ↑ Esteva de Antonio, Isabel; Gómez-Gil, Esther; Almaraz, M. ª Cruz; Martínez-Tudela, Juana; Bergero, Trinidad; Olveira, Gabriel; Soriguer, Federico (2012-06-01). "Organization of healthcare for transsexual persons in the Spanish national health system". Gaceta Sanitaria. 26 (3): 203–209. doi:10.1016/j.gaceta.2011.10.021. ISSN 0213-9111. PMID 22402241.
  52. ↑ "Forced Sterilisation of Trans People". RSFL. 2017-03-25.
  53. ↑ Jessica Lundgren (2013-01-10). "Tvångssterilisering vid könskorrigering blir äntligen olagligt". QX.
  54. 1 2 Lundströmmottagningen, Västra Götalandsregionen. (2016-11-28). "Könsdysfori och Utredning".
  55. ↑ Ingemar Karlsson Gadea (2016-11-10). "Patient Fees". 1177.
  56. ↑ RSFL (2015-11-27). "Trans Health Care".
  57. ↑ "Namn". Skatteverket (in Swedish). Retrieved March 2, 2021.
  58. ↑ Richard Ekman and Johannes Kardell (21 November 2016). "Transaktivister har ockuperat Socialstyrelsen". SVT Nyheter. SVT.
  59. 1 2 3 Davies, Andrew; Bouman, Walter Pierre; Richards, Christina; Barrett, James; Ahmad, Sheraz; Baker, Karen; Lenihan, Penny; Lorimer, Stuart; Murjan, Sarah (2013-11-01). "Patient satisfaction with gender identity clinic services in the United Kingdom". Sexual and Relationship Therapy. 28 (4): 400–418. doi:10.1080/14681994.2013.834321. ISSN 1468-1994. S2CID 145216924.
  60. ↑ "LGBT In Britain - Trans Report" (PDF). Stonewall. Retrieved 5 September 2020.
  61. ↑ "Local access to healthcare for transgender patients lacking, one advocate says". CBS News. January 27, 2016. Retrieved January 3, 2017.
  62. ↑ "Canadian Transgender Youth Health Survey". Stigma and Resilience Among Vulnerable Youth Centre. The University of British Columbia. Retrieved January 3, 2017.
  63. ↑ Daniel McHardie (June 3, 2016). "New Brunswick will now cover gender-confirming surgeries". CBS News. Retrieved January 3, 2017.
  64. ↑ Melissa Fundira (May 3, 2016). "Arson at Montreal clinic concerns trans people awaiting surgery". CBC News. Retrieved January 3, 2017.
  65. ↑ "Ontario expands referrals for gender reassignment surgery". CBS News. November 6, 2015. Retrieved January 3, 2017.
  66. ↑ "Canada's health care doesn't meet the needs of transgender patients". CBC Radio. January 15, 2016. Retrieved January 3, 2017.
  67. ↑ "Publicly Funded Transition-related Medical Care in Canada" (PDF). UFCW Canada. Retrieved January 3, 2017.
  68. ↑ "Eligibility criteria for trans individuals". blood.ca. Retrieved 30 June 2017.
  69. ↑ "Canadian Blood Services places restrictions on transgender donors". cbc.ca. Retrieved 30 June 2017.
  70. ↑ "Canadian Blood Services Annual Report 2018-2019" (PDF). Retrieved 2 February 2021.
  71. 1 2 3 Mayela Sánchez (December 18, 2016). "Transgender People in Mexico City Resort to Dangerous Unsupervised Procedures". Global Press Journal. Retrieved January 3, 2017.
  72. ↑ "Report on Human Rights Conditions of Transgender Women in Mexico" (PDF). Transgender Law Center. May 2016. Retrieved January 3, 2017.
  73. ↑ Pam Belluck (July 26, 2016). "W.H.O. Weighs Dropping Transgender Identity From List of Mental Disorders". The New York Times. Retrieved January 3, 2017.
  74. ↑ Bradford, Judith; Reisner, Sari L.; Honnold, Julie A.; Xavier, Jessica (2012-11-15). "Experiences of Transgender-Related Discrimination and Implications for Health: Results From the Virginia Transgender Health Initiative Study". American Journal of Public Health. 103 (10): 1820–1829. doi:10.2105/AJPH.2012.300796. ISSN 0090-0036. PMC 3780721. PMID 23153142.
  75. ↑ Varny J. (2016). Rainbow Medicine- Supporting the Needs of Lesbian, gay, bisexual, and trans patients. Journal of Clinical Medicine.
  76. 1 2 3 Bianchi, Fernanda T.; Reisen, Carol A.; Zea, Maria Cecilia; Vidal-Ortiz, Salvador; Gonzales, Felisa A.; Betancourt, Fabián; Aguilar, Marcela; Poppen, Paul J. (2014-01-24). "Sex Work Among Men Who Have Sex with Men and Transgender Women in Bogotá". Archives of Sexual Behavior. 43 (8): 1637–1650. doi:10.1007/s10508-014-0260-z. ISSN 0004-0002. PMC 4110190. PMID 24464550.
  77. 1 2 Chen, Diane; Hidalgo, Marco A.; Leibowitz, Scott; Leininger, Jennifer; Simons, Lisa; Finlayson, Courtney; Garofalo, Robert (2016). "Multidisciplinary Care for Gender-Diverse Youth: A Narrative Review and Unique Model of Gender-Affirming Care". Transgender Health. 1 (1): 117–123. doi:10.1089/trgh.2016.0009. PMC 5549539. PMID 28861529.
  78. ↑ Taylor, Mark. "An Insight into the Life of a Transgender Child". LinkedIn. Retrieved 28 June 2017.
  79. ↑ Wilson, Erin C.; Chen, Yea-Hung; Arayasirikul, Sean; Raymond, H. Fisher; McFarland, Willi (2016-04-26). "The Impact of Discrimination on the Mental Health of Trans*Female Youth and the Protective Effect of Parental Support". AIDS and Behavior. 20 (10): 2203–2211. doi:10.1007/s10461-016-1409-7. ISSN 1090-7165. PMC 5025345. PMID 27115401.
  80. 1 2 3 Radix, Anita; Silva, Manel (2014). "Beyond the Guidelines: Challenges, Controversies, and Unanswered Questions". Pediatric Annals. 43 (6): e145–e150. doi:10.3928/00904481-20140522-10. PMID 24972423.
  81. ↑ Chew, Denise; Anderson, Jemma; Williams, Katrina; May, Tamara; Pang, Kenneth (2018-04-01). "Hormonal Treatment in Young People With Gender Dysphoria: A Systematic Review". Pediatrics. 141 (4): e20173742. doi:10.1542/peds.2017-3742. PMID 29514975.
  82. ↑ "Aging". National Center for Transgender Equality. Retrieved 2019-03-24.
  83. ↑ de Vries, Brian; Gutman, Gloria; Humble, Áine; Gahagan, Jacqueline; Chamberland, Line; Aubert, Patrick; Fast, Janet; Mock, Steven (2019-03-14). "End-of-Life Preparations Among LGBT Older Canadian Adults: The Missing Conversations" (PDF). The International Journal of Aging and Human Development. 88 (4): 358–379. doi:10.1177/0091415019836738. ISSN 0091-4150. PMID 30871331. S2CID 78094482.
  84. ↑ Reygan, Finn; Henderson, Neil (2019-03-21). "All Bad? Experiences of Aging Among LGBT Elders in South Africa". The International Journal of Aging and Human Development. 88 (4): 405–421. doi:10.1177/0091415019836929. hdl:10566/6338. ISSN 0091-4150. PMID 30897921. S2CID 85446146.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.